Chakraborty, Nitya G. - University of Connecticut

个人简介

B.Sc. University of Calcutta, Chemistry, Physics, Math M.S. Institute of Chemists Chemistry/ Biochemistry Ph.D. Patna University, Chemistry

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Knockdown of T-bet expression in Mart-127-35 -specific T-cell-receptor-engineered human CD4(+) CD25(-) and CD8(+) T cells attenuates effector function.Jha, Sidharth S; Chakraborty, Nitya G; Singh, Prashant; Mukherji, Bijay; Dorsky, David I Immunology 2014 Dec;145(1):124-35 Manipulation of regulatory T cells and antigen-specific cytotoxic T lymphocyte-based tumour immunotherapy.Karimi, Shirin; Chattopadhyay, Subhasis; Chakraborty, Nitya G Immunology 2014 Sep;144(2):186-96 Analyses of T cell-mediated immune response to a human melanoma-associated antigen by the young and the elderly.Chakraborty, Nitya G; Yadav, Meeta; Dadras, Soheil S; Singh, Prashant; Chhabra, Arvind; Feinn, Richard; Kerr, Phillip E; Grant-Kels, Jane M; Mukherji, Bijay; Hegde, Upendra P Human immunology 2013 May;74(5):640-7 Metastatic melanoma in the older patient: immunologic insights and treatment outcomes.Hegde, Upendra P; Chakraborty, Nitya; Mukherji, Bijay; Grant Kels, Jane M Expert review of pharmacoeconomics & outcomes research 2011 Apr;11(2):185-93 MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.Ray, Swagatam; Chhabra, Arvind; Chakraborty, Nitya G; Hegde, Upendra; Dorsky, David I; Chodon, Thinle; von Euw, Erika; Comin-Anduix, Begonya; Koya, Richard C; Ribas, Antoni; Economou, James S; Rosenberg, Steven A; Mukherji, Bijay Clinical immunology (Orlando, Fla.) 2010 Sep;136(3):338-47 Fabrication and biocompatibility investigation of TiO(2) films on the polymer substrates obtained via a novel and versatile route.Ou, Junfei; Wang, Jinqing; Zhang, Dong; Zhang, Puliang; Liu, Sheng; Yan, Penghua; Liu, Bin; Yang, Shengrong Colloids and surfaces. B, Biointerfaces 2010 Mar;76(1):123-7 The oxazolidinone derivative locostatin induces cytokine appeasement.Ménoret, Antoine; McAleer, Jeremy P; Ngoi, Soo-Mun; Ray, Swagatam; Eddy, Nicholas A; Fenteany, Gabriel; Lee, Seung-Joo; Rossi, Robert J; Mukherji, Bijay; Allen, David L; Chakraborty, Nitya G; Vella, Anthony T Journal of immunology (Baltimore, Md. : 1950) 2009 Dec;183(11):7489-96 Inhibition of superoxide generation upon T-cell receptor engagement rescues Mart-1(27-35)-reactive T cells from activation-induced cell death.Norell, H?kan; Martins da Palma, Telma; Lesher, Aaron; Kaur, Navtej; Mehrotra, Meenal; Naga, Osama S; Spivey, Natalie; Olafimihan, Seye; Chakraborty, Nitya G; Voelkel-Johnson, Christina; Nishimura, Michael I; Mukherji, Bijay; Mehrotra, Shikhar Cancer research 2009 Aug;69(15):6282-9 Melanoma in the elderly patient: relevance of the aging immune system.Hegde, Upendra P; Chakraborty, Nitya; Kerr, Philip; Grant-Kels, Jane M Clinics in dermatology 2009 Jan;27(6):537-44 Obstacles to and opportunities for more effective peptide-based therapeutic immunization in human melanoma.Ray, Swagatam; Chhabra, Arvind; Mehrotra, Shikhar; Chakraborty, Nitya G; Ribas, Antoni; Economou, James; Mukherji, Bijay Clinics in dermatology 2009 Jan;27(6):603-13 CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model.Chhabra, Arvind; Yang, Lili; Wang, Pin; Comin-Anduix, Bego?a; Das, Raja; Chakraborty, Nitya G; Ray, Swagatam; Mehrotra, Shikhar; Yang, Haiguang; Hardee, Cinnamon L; Hollis, Roger; Dorsky, David I; Koya, Richard; Kohn, Donald B; Ribas, Antoni; Economou, James S; Baltimore, David; Mukherji, Bijay Journal of immunology (Baltimore, Md. : 1950) 2008 Jul;181(2):1063-70 Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-1 27-35.Chhabra, Arvind; Chakraborty, Nitya G; Mukherji, Bijay Clinical immunology (Orlando, Fla.) 2008 Mar;126(3):251-9 Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes.Hegde, Upendra; Chhabra, Arvind; Chattopadhyay, Subhasis; Das, Raja; Ray, Swagatam; Chakraborty, Nitya G Pathobiology : journal of immunopathology, molecular and cellular biology 2008 Jan;75(3):200-8 Inhibition of c-Jun N-terminal kinase rescues influenza epitope-specific human cytolytic T lymphocytes from activation-induced cell death.Mehrotra, Shikhar; Chhabra, Arvind; Hegde, Upendra; Chakraborty, Nitya G; Mukherji, Bijay Journal of leukocyte biology 2007 Feb;81(2):539-47 Activation-induced cell death of human melanoma specific cytotoxic T lymphocytes is mediated by apoptosis-inducing factor.Chhabra, Arvind; Mehrotra, Shikhar; Chakraborty, Nitya G; Dorsky, David I; Mukherji, Bijay European journal of immunology 2006 Dec;36(12):3167-74 Effect of CD4+CD25+ and CD4+CD25- T regulatory cells on the generation of cytolytic T cell response to a self but human tumor-associated epitope in vitro.Chattopadhyay, Subhasis; Mehrotra, Shikhar; Chhabra, Arvind; Hegde, Upendra; Mukherji, Bijay; Chakraborty, Nitya G Journal of immunology (Baltimore, Md. : 1950) 2006 Jan;176(2):984-90 Macrophages as stimulators of MART-1 27-35 epitope-specific human cytolytic T lymphocytes in vitro.Mehrotra, Shikhar; Zaidi, Nisar; Chakraborty, Nitya G; Mukherji, Bijay Pathobiology : journal of immunopathology, molecular and cellular biology 2006 Jan;73(5):238-43 Tumor-associated antigen and antigen-presenting cells based vaccine therapy for cancerChakraborty N.G. Indian Journal of Human Genetics 2006 Jan;12(2):53-65 Continuous presence of Th1 conditions is necessary for longer lasting tumor-specific CTL activity in stimulation cultures with PBL.Chattopadhyay, Subhasis; Chakraborty, Nitya G Human immunology 2005 Aug;66(8):884-91 Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells.Mehrotra, Shikhar; Chhabra, Arvind; Chakraborty, Abolokita; Chattopadhyay, Subhasis; Slowik, Mark; Stevens, Robert; Zengou, Ryan; Mathias, Clinton; Butterfield, Lisa H; Dorsky, David I; Economou, James S; Mukherji, Bijay; Chakraborty, Nitya G Immunology 2004 Dec;113(4):472-81 Rescuing melanoma epitope-specific cytolytic T lymphocytes from activation-induced cell death, by SP600125, an inhibitor of JNK: implications in cancer immunotherapy.Mehrotra, Shikhar; Chhabra, Arvind; Chattopadhyay, Subhasis; Dorsky, David I; Chakraborty, Nitya G; Mukherji, Bijay Journal of immunology (Baltimore, Md. : 1950) 2004 Nov;173(10):6017-24 Cross-presentation of a human tumor antigen delivered to dendritic cells by HSV VP22-mediated protein translocation.Chhabra, Arvind; Mehrotra, Shikhar; Chakraborty, Nitya G; Mukherji, Bijay; Dorsky, David I European journal of immunology 2004 Oct;34(10):2824-33 Regulatory T-cell response and tumor vaccine-induced cytotoxic T lymphocytes in human melanoma.Chakraborty, Nitya G; Chattopadhyay, Subhasis; Mehrotra, Shikhar; Chhabra, Arvind; Mukherji, Bijay Human immunology 2004 Aug;65(8):794-802 Recognition of PSA-derived peptide antigens by T cells from prostate cancer patients without any prior stimulation.Chakraborty, Nitya G; Stevens, Robert L; Mehrotra, Shikhar; Laska, Elizabeth; Taxel, Pamela; Sporn, Jonathan R; Schauer, Peter; Albertsen, Peter C Cancer immunology, immunotherapy : CII 2003 Aug;52(8):497-505 Stimulatory and inhibitory differentiation of human myeloid dendritic cells.Chakraborty, A; Li, L; Chakraborty, N G; Mukherji, B Clinical immunology (Orlando, Fla.) 2000 Feb;94(2):88-98